Aggregated
No track record data- Bullish
- 8
- Hold
- 0
- Bearish
- 0
Jefferies
A Jefferies analyst with 14 tracked ratings across 9 distinct tickers has a 2.2-star track record and a 50% success rate on the captured sample, covering three different sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| VOR | 2026-03-30 | buy | $50.00 | Aggregated |
| VOR | 2026-03-29 | buy | $50.00 | Aggregated |
| RLMD | 2025-12-22 | buy | $9.00 | Aggregated |
| RLMD | 2025-12-21 | buy | $9.00 | Aggregated |
| VERA | 2025-11-26 | buy | $45.00 | Aggregated |
| RIGL | 2025-11-05 | buy | $42.00 | Aggregated |
| NUVB | 2025-09-30 | buy | $10.00 | Aggregated |
| NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A | 2025-09-30 | unknown | $10.00 | Aggregated |
| NUVB | 2025-09-29 | buy | $10.00 | Aggregated |
| HOWL | 2025-08-04 | buy | $4.00 | Aggregated |
| PYXS | 2024-05-07 | buy | $10.00 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 2024-05-07 | unknown | $10.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| VOR | 3 | 2026-03-30 | Aggregated |
| RLMD | 2 | 2025-12-22 | Aggregated |
| VERA | 2 | 2025-11-26 | Aggregated |
| RIGL | 1 | 2025-11-05 | Aggregated |
| NUVB | 2 | 2025-09-30 | Aggregated |
| NUVBNUVATION BIO INC - ORDINARY SHARES - CLASS A | 1 | 2025-09-30 | Aggregated |
| HOWL | 1 | 2025-08-04 | Aggregated |
| PYXS | 1 | 2024-05-07 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 1 | 2024-05-07 | Aggregated |